Key result
An editorial discussing a study of 3093 Medicare beneficiaries aged 65 years and older with acute myocardial infarction, examining the use of thrombolytic therapy in the elderly.
Answers are grounded in this paper and cite their sources.
This editorial highlights the debate over whether the low use of thrombolytic therapy in elderly patients with acute myocardial infarction reflects age bias or appropriate clinical caution.
Given the low survival experience of older persons following acute myocardial infarction,¹claims that thrombolytic therapy is underused in this patient population are particularly disconcerting. Regional, national, and multinational populationbased studies of age-related patterns of thrombolytic use have provided support for these assertions.²,³It is unclear, however, to what extent these patterns of care reflect age bias in the use of an effective therapy vs the appropriately cautious use of a treatment that carries inherent risks and for which only a limited number of elderly patients with acute myocardial infarction are eligible. In this issue of TheJOURNAL, Krumholz et al⁴provide evidence suggesting that the answer to this question probably lies somewhere between these 2 extremes. See also p 1683. In their study, the authors carefully analyzed data from the medical records of 3093 Medicare beneficiaries, aged 65 years and older, admitted to all acute care
No takes yet. Share an insight, caveat, or question.
Jerry H. Gurwitz (1997) conducted an editorial in Acute myocardial infarction (n=3,093). Coronary Thrombolysis was evaluated. An editorial discussing a study of 3093 Medicare beneficiaries aged 65 years and older with acute myocardial infarction, examining the use of thrombolytic therapy in the elderly.
Synapse has enriched 10 related papers. Consider them for comparative context: